Presacral Clear Cell Carcinoma of Müllerian Origin 20 Years After Hysterectomy and Bilateral Salpingo-Oophorectomy: A Case Report and Literature Review.
Primary presacral clear cell carcinoma (CCC) of Müllerian origin is extremely rare. Malignant transformation of endometriosis is a known phenomenon, though typically involving the ovaries or pelvic peritoneum. Retroperitoneal presentation, …
Published: Nov. 7, 2025, midnight
Association Between the C-Reactive Protein-Albumin-Lymphocyte Index and Endometriosis: Insights from the 1999-2006 National Health and Nutrition Examination Survey.
The C-reactive protein-albumin-lymphocyte (CALLY) index serves as an integrated indicator, reflecting the interplay between systemic inflammation, immune competence, and nutritional health. While validated in other chronic diseases, its relevance to …
Published: Nov. 7, 2025, midnight
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - The Malaysian Reserve
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health The Malaysian Reserve
Published: Nov. 6, 2025, 8:25 p.m.
Association Between Previous Surgical Treatment and Outcomes of Repeat Endometriosis Surgery - medtalks.in
Association Between Previous Surgical Treatment and Outcomes of Repeat Endometriosis Surgery medtalks.in
Published: Nov. 6, 2025, 11:13 a.m.
Is There Really a Cancer Epidemic in Younger Adults? - Medscape
Is There Really a Cancer Epidemic in Younger Adults? Medscape
Published: Nov. 6, 2025, 10:07 a.m.
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - Fidelity
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health Fidelity
Published: Nov. 6, 2025, 4:32 a.m.
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - PR Newswire
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health PR Newswire
Published: Nov. 6, 2025, 4:08 a.m.
Hormonal contraceptives linked to higher breast cancer risk, study finds - The Eastleigh Voice
Hormonal contraceptives linked to higher breast cancer risk, study finds The Eastleigh Voice
Published: Nov. 6, 2025, 3:53 a.m.
Evolution of an ovarian endometriotic cyst into clear cell carcinoma with squamous differentiation across two pregnancies: A case report.
Ovarian clear cell carcinoma (OCCC) during pregnancy is exceedingly rare, particularly when accompanied by squamous differentiation, with only a limited number of cases reported in the English literature to date.
Published: Nov. 6, 2025, midnight
Endometriosis in African women: Findings from a cohort of reproductive-age women attending an endometriosis ultrasound training program.
Delays in the diagnosis of endometriosis in sub Saharan Africa persist, driven partly by limited access to advanced imaging techniques. Capacity building initiatives focused on ultrasound offer a practical and …
Published: Nov. 6, 2025, midnight